Scholarlink

<p>Traditionally people use the decoction of dried Prunes for treatment of Diabetes mellitus, cardiovascular diseases. The present study aimed to investigate the antidiabetic potential of methanolic extract of endocarp of <i>Prunus domestica</i> L. through both in vitro and in vivo experimental models. GC–MS analysis for identification of phytoconstituents followed by in-silico and ADME studies. The antidiabetic potential was assessed via α-amylase inhibitory assay and oral glucose tolerance test. For in vivo evaluation, diabetes was induced in mice using alloxan (125&#xa0;mg/kg) and metformin was employed as the standard reference drug. Phytochemical quantification revealed significant levels of total phenolics (96.18 ± 2.08&#xa0;mg/g GAE) and flavonoids (76.96 ± 0.71&#xa0;mg/g QE). The extract demonstrated substantial α-amylase inhibition (84.71%) and exhibited 51.034% glycemic reduction in the oral glucose tolerance test (OGTT). In vivo, treatment with <i>P. domestica</i> endocarp extract resulted in a significant reduction in blood glucose level; compared to untreated diabetic controls. Biochemical assessments indicated marked reductions in serum levels of urea, creatinine, cholesterol, low-density lipoprotein (LDL), and alkaline phosphatase (ALP) at a treatment dose of 400&#xa0;mg/kg (<i>p</i> &lt; 0.001), compared to diabetic control animals. Methanolic extract of <i>Prunus domestica</i> endocarp exhibited restoration of liver and pancreatic histology as compared to untreated diabetic controls that had been damage by Alloxan induce DM. Standardization of methanol extract of <i>Prunus domestica</i> endocarp via GC–MS analysis discovered potent phytoconstituents, a molecular docking and ADME studies reported that Coronarin E and 9-octadecenoic acid may be promising drug candidate on basis of theoretical knowledge which must be validated by using experimental studies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of antidiabetic potential of Prunus domestica L. endocarp extract: histopathological, biochemical, in-silico molecular docking and pharmacokinetic studies

  • 期刊论文

  • 发表日期：

    2026年2月14日

查看全文
  • Anam Yasmeen,
  • Muhammad Islam,
  • Hamid Saeed,
  • Abrar Ahmed

摘要

Traditionally people use the decoction of dried Prunes for treatment of Diabetes mellitus, cardiovascular diseases. The present study aimed to investigate the antidiabetic potential of methanolic extract of endocarp of Prunus domestica L. through both in vitro and in vivo experimental models. GC–MS analysis for identification of phytoconstituents followed by in-silico and ADME studies. The antidiabetic potential was assessed via α-amylase inhibitory assay and oral glucose tolerance test. For in vivo evaluation, diabetes was induced in mice using alloxan (125 mg/kg) and metformin was employed as the standard reference drug. Phytochemical quantification revealed significant levels of total phenolics (96.18 ± 2.08 mg/g GAE) and flavonoids (76.96 ± 0.71 mg/g QE). The extract demonstrated substantial α-amylase inhibition (84.71%) and exhibited 51.034% glycemic reduction in the oral glucose tolerance test (OGTT). In vivo, treatment with P. domestica endocarp extract resulted in a significant reduction in blood glucose level; compared to untreated diabetic controls. Biochemical assessments indicated marked reductions in serum levels of urea, creatinine, cholesterol, low-density lipoprotein (LDL), and alkaline phosphatase (ALP) at a treatment dose of 400 mg/kg (p < 0.001), compared to diabetic control animals. Methanolic extract of Prunus domestica endocarp exhibited restoration of liver and pancreatic histology as compared to untreated diabetic controls that had been damage by Alloxan induce DM. Standardization of methanol extract of Prunus domestica endocarp via GC–MS analysis discovered potent phytoconstituents, a molecular docking and ADME studies reported that Coronarin E and 9-octadecenoic acid may be promising drug candidate on basis of theoretical knowledge which must be validated by using experimental studies.